ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
映恩生物-B
256.000
-7.200
-2.74%
手动刷新
成交量:
42.99万
成交额:
1.12亿
市值:
230.75亿
市盈率:
-5.69
高:
272.000
开:
265.000
低:
254.200
收:
263.200
52周最高:
563.500
52周最低:
165.500
股本:
9,013.77万
香港流通股本:
9,013.77万
量比:
0.56
换手率:
0.48%
股息:
- -
股息率:
- -
每股收益(LYR):
-44.998
净资产收益率:
-1282.14%
总资产收益率:
-10.17%
市净率:
8.41
市盈率(LYR):
-5.69
市销率:
11.02
数据加载中...
总览
公司
新闻资讯
公告
映恩生物-B(09606)出现大手卖出6.7万股,成交价$258.0,涉资1.729千万
阿斯达克财经
·
03/24
映恩生物(09606.HK)委任首席财务官
阿斯达克财经
·
03/24
《业绩》映恩生物(09606.HK)全年亏损扩至25.95亿人民币
阿斯达克财经
·
03/23
映恩生物-B(09606)2025年实现收入约18.52亿元 管线开发与业务运营取得重大进展
智通财经
·
03/23
映恩生物-B(09606):花海清获委任为公司执行董事
智通财经
·
03/23
【券商聚焦】华源证券首予映恩生物(09606)“买入”评级 指公司出海全球化有望进展顺利
金吾财讯
·
03/18
映恩生物-B(09606)出现大手买入1.68万股,成交价$299.0,涉资502.32万
阿斯达克财经
·
03/17
映恩生物-B(09606)股价上升5.03%,现价港币$284.0
阿斯达克财经
·
03/16
每日卖空追踪 | 映恩生物-B 03月12日卖空量成交5.31万股,卖空比例为7.94%
市场透视
·
03/12
映恩生物-B:董事会会议日期
香港交易所
·
03/11
映恩生物-B(09606)股价下跌8.04%,现价港币$297.4
阿斯达克财经
·
03/11
每日卖空追踪 | 映恩生物-B 03月09日卖空量成交8.29万股,卖空比例为11.44%
市场透视
·
03/09
映恩生物-B盘中异动 早盘股价大跌5.01%
市场透视
·
03/09
【国投证券 | 医药】新药周观点:映恩B7H3 ADC展现mCRPC领域BIC潜力,后续多个二代IO+ADC数据读出值得期待
国投证券医药研究
·
03/08
港股通3月调整前瞻:44只港股有望纳入 英硅智能(03696)、京东工业(07618)等在列
智通财经
·
03/06
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
金吾财讯
·
03/06
每日卖空追踪 | 映恩生物-B 03月05日卖空量成交3.97万股,卖空比例为4.56%
市场透视
·
03/05
映恩生物-B盘中异动 早盘急速拉升5.05%报299.400港元
市场透视
·
03/05
映恩生物-B03月03日主力净流出191.1万元 散户资金买入
市场透视
·
03/03
医药行业跟踪报告:中国创新ADC闪耀ASCO GU,长效三靶点减肥药二期临床成功
爱建证券
·
03/02
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/09606/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":256,"timestamp":1774512497009,"preClose":263.2,"halted":0,"volume":429927,"delay":0,"changeRate":-0.02735562310030391,"floatShares":90137700,"shares":90137700,"eps":-44.99799481877451,"marketStatus":"未开盘","change":-7.2,"latestTime":"03-26 16:08:17","open":265,"high":272,"low":254.2,"amount":112200123,"amplitude":0.067629,"askPrice":256,"askSize":1800,"bidPrice":255.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-36.03457514733621,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":263.2,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"volumeRatio":0.5647588937339876,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90137700,"roa":"-10.17%","roe":"-1282.14%","lyrEps":-44.997995,"volumeRatio":0.5647588937339876,"shares":90137700,"dividePrice":0,"high":272,"amplitude":0.067629,"preClose":263.2,"low":254.2,"week52Low":165.5,"pbRate":"8.41","psRate":"11.02","week52High":563.5,"institutionHeld":0,"latestPrice":256,"committee":-0.894737,"eps":-44.99799481877451,"divideRate":0,"volume":429927,"delay":0,"ttmEps":-36.03457514733621,"open":265,"prevYearClose":298.2,"prevWeekClose":280.2,"prevMonthClose":315,"prevQuarterClose":298.2,"fiveDayClose":284.2,"twentyDayClose":316.8,"sixtyDayClose":313},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1761235200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-03-25","current":-7.094595,"percent":0.957082,"low":-29.984477,"twenty":-19.244315,"median":-9.964865,"eighty":-8.862465,"high":-7.368305,"avg":-13.781591,"sd":6.287464,"marketCap":23724246324},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-25","current":-8.071366,"twenty":-19.244315,"median":-9.964865,"eighty":-8.862465,"marketCap":23724246324}],"updateTime":1774512793758},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621405808","title":"映恩生物-B(09606)出现大手卖出6.7万股,成交价$258.0,涉资1.729千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2621405808","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621405808?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 13:04","pubTimestamp":1774328640,"startTime":"0","endTime":"0","summary":"[大手成交]映恩生物-B(09606)在下午01:04出现大手卖出,成交量为6.7万,成交价为港币$258.0,涉资1.729千万。至目前为止,股价跌3.632%,今日最高价为$277.2,而最低价为$254.6,总成交量为75.137万股,总成交金额港币$1.97亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603245913/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603245913/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09606","HK0000500386.USD","HK0000252152.HKD","BK1161","LU2543165471.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2621039428","title":"映恩生物(09606.HK)委任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2621039428","media":"阿斯达克财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621039428?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 09:22","pubTimestamp":1774315320,"startTime":"0","endTime":"0","summary":"映恩生物-B(09606.HK) 公布,委任张韶壬为公司首席财务官,自上日(23日)起生效。(ca/da)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-23 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250409114929116_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250409114929116_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511696/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511696/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09606","BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD"],"gpt_icon":0},{"id":"2621339707","title":"《业绩》映恩生物(09606.HK)全年亏损扩至25.95亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2621339707","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621339707?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 23:05","pubTimestamp":1774278300,"startTime":"0","endTime":"0","summary":"映恩生物-B(09606.HK) 公布2025年度业绩,收入录得18.52亿人民币(下同),按年下降4.6%。亏损由上年度10.5亿元,扩至25.95亿元,每股亏损39.8元。不派末期息。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-23 16:25。)过往派息公布日期派息事项派息内容2025/08/26中期业绩无派息AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250409114925428_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250409114925428_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511591/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511591/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000252152.HKD","MCNHmain","BK1161","MUCmain","HK0000252160.HKD","UCmain","09606","HK0000500386.USD","CYB","LU2543165471.USD","CNHmain"],"gpt_icon":0},{"id":"2621170634","title":"映恩生物-B(09606)2025年实现收入约18.52亿元 管线开发与业务运营取得重大进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2621170634","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621170634?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 20:53","pubTimestamp":1774270392,"startTime":"0","endTime":"0","summary":"智通财经APP讯,映恩生物-B 公布2025年业绩,收入约18.52亿元,毛利约5.89亿元,研究与开发开支约8.38亿元,同比增长0.12%。截至目前,该集团拥有10款处于临床阶段的ADC管线,并于全球的临床试验中入组逾3,200例患者。当中包括仅于2025年便迅速入组逾1,200例患者,其中约50%位于美国、欧盟、澳洲及中国境外其他地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"映恩生物-B(09606)2025年实现收入约18.52亿元 管线开发与业务运营取得重大进展","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","BK1161"],"gpt_icon":0},{"id":"2621705955","title":"映恩生物-B(09606):花海清获委任为公司执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705955","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705955?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 20:34","pubTimestamp":1774269248,"startTime":"0","endTime":"0","summary":"智通财经APP讯,映恩生物-B(09606)发布公告,自2026年3月23日起:(1)司文女士辞任公司执行董事及薪酬委员会成员;(2)花海清博士获委任为公司执行董事;(3)张韶壬先生获委任为公司首席财务官;(4)朱忠远博士获委任为公司薪酬委员会成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","09606","BK1161","LU2543165471.USD"],"gpt_icon":0},{"id":"2620283458","title":"【券商聚焦】华源证券首予映恩生物(09606)“买入”评级 指公司出海全球化有望进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2620283458","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620283458?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 10:51","pubTimestamp":1773802304,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华源证券发研报指,映恩生物 于2020年正式运营,是一家临床阶段的创新生物药企,专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物。2024年BioNTech研发日提出PD-L1/VEGF双抗联合单抗ADC疗法策略,肿瘤治疗策略进入新的开发时代。鉴于公司在ADC领域的优势地位,未来肿瘤疗法迭代布局靠前,出海全球化有望进展顺利,首次覆盖,给予“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976726","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","161027"],"gpt_icon":0},{"id":"2620841126","title":"映恩生物-B(09606)出现大手买入1.68万股,成交价$299.0,涉资502.32万","url":"https://stock-news.laohu8.com/highlight/detail?id=2620841126","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620841126?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 10:15","pubTimestamp":1773713700,"startTime":"0","endTime":"0","summary":"[大手成交]映恩生物-B(09606)在上午10:15出现大手买入,成交量为1.68万,成交价为港币$299.0,涉资502.32万。至目前为止,股价升5.282%,今日最高价为$299.0,而最低价为$284.6,总成交量为30.814万股,总成交金额港币$9.025千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603175414/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603175414/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2543165471.USD","HK0000500386.USD","09606","HK0000252152.HKD","BK1161","HK0000252160.HKD"],"gpt_icon":0},{"id":"2619480171","title":"映恩生物-B(09606)股价上升5.03%,现价港币$284.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2619480171","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619480171?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 10:10","pubTimestamp":1773627000,"startTime":"0","endTime":"0","summary":"[上升股]映恩生物-B(09606) 股价在上午10:10比前收市价上升5.03%,现股价为港币$284.0。至目前为止,今日最高价为$284.0,而最低价为$267.0。总成交量为17.828万股,总成交金额为港币$4.917千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603161080/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603161080/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000500386.USD","BK1161","HK0000252160.HKD","09606","HK0000252152.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2618913457","title":"每日卖空追踪 | 映恩生物-B 03月12日卖空量成交5.31万股,卖空比例为7.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618913457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618913457?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 16:30","pubTimestamp":1773304243,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月12日,跌4.41%,卖空量成交5.31万股,较上一交易日减少80.6%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163617a6ba536f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163617a6ba536f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","09606","HK0000252160.HKD","BK1161","LU2543165471.USD","HK0000500386.USD"],"gpt_icon":0},{"id":"2618726249","title":"映恩生物-B:董事会会议日期","url":"https://stock-news.laohu8.com/highlight/detail?id=2618726249","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618726249?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 16:30","pubTimestamp":1773217843,"startTime":"0","endTime":"0","summary":"映恩生物宣布将于2026年3月23日(星期一)召开董事会会议,主要议程包括审议及批准公司及其附属公司截至2025年12月31日止年度的年度业绩,同时将考虑建议派付末期股息事宜。会议将由董事会主席、执行董事兼首席执行官朱忠远博士主持,出席会议的董事会成员包括三名执行董事、两名非执行董事及三名独立非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031117471097ad7b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031117471097ad7b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2543165471.USD","09606","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2618907899","title":"映恩生物-B(09606)股价下跌8.04%,现价港币$297.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2618907899","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618907899?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 13:05","pubTimestamp":1773205500,"startTime":"0","endTime":"0","summary":"[下跌股]映恩生物-B(09606) 股价在下午01:05比前收市价下跌8.04%,现股价为港币$297.4。至目前为止,今日最高价为$328.0,而最低价为$297.4。总成交量为84.415万股,总成交金额为港币$2.573亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603111117/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603111117/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000500386.USD","BK1161","09606","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2618642772","title":"每日卖空追踪 | 映恩生物-B 03月09日卖空量成交8.29万股,卖空比例为11.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642772?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 16:30","pubTimestamp":1773045041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月09日,跌0.82%,卖空量成交8.29万股,较上一交易日减少74.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163614a6b1c9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163614a6b1c9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","LU2543165471.USD","09606","BK1161"],"gpt_icon":0},{"id":"2618642703","title":"映恩生物-B盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642703?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 09:31","pubTimestamp":1773019911,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分,映恩生物-B股票出现异动,股价大幅下挫5.01%。截至发稿,该股报299.800港元/股,成交量3.51万股,换手率0.04%,振幅3.23%。映恩生物-B股票所在的生物技术行业中,整体跌幅为2.03%。其相关个股中,科济药业-B、维立志博-B、派格生物医药-B涨幅较大,振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B,振幅分别为16.47%、12.39%、12.31%。映恩生物-B公司简介:映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909315197aa99b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909315197aa99b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","BK1161","HK0000500386.USD","09606"],"gpt_icon":0},{"id":"2618939926","title":"【国投证券 | 医药】新药周观点:映恩B7H3 ADC展现mCRPC领域BIC潜力,后续多个二代IO+ADC数据读出值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939926","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618939926?lang=zh_cn&edition=fundamental","pubTime":"2026-03-08 20:28","pubTimestamp":1772972929,"startTime":"0","endTime":"0","summary":"截至2025年12月29日,共纳入146例既往接受过多线治疗的mCRPC患者,中位年龄为70岁,中位既往治疗线数为4线。这是B7H3 ADC类药物,首次在Lu 177经治的mCRPC患者中展现出优异的持久疗效。中国生物制药有权获得最高15.3亿美元的付款,其中包括1.35亿美元的首付款以及里程碑付款。德琪医药将获得总计8,000万美元的首付款及近期里程碑付款,并有望在未来获得","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308203514a4582528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308203514a4582528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2543165471.USD","BK1515","09606","BK1574","HK0000500386.USD","HK0000252160.HKD","09939","HK0000252152.HKD"],"gpt_icon":0},{"id":"2617502435","title":"港股通3月调整前瞻:44只港股有望纳入 英硅智能(03696)、京东工业(07618)等在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2617502435","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617502435?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 13:56","pubTimestamp":1772776602,"startTime":"0","endTime":"0","summary":"考虑恒生综指成分股的要求,再考虑纳入港股通的额外标准,此次或共有44只股票符合纳入港股通标准,包括:东亚银行、周大福创建、滴普科技、乐舒适、创新实业、奇富科技-S、京东工业、英硅智能、健康160、中慧生物-B、宝济药业-B、派格生物医药-B、劲方医药-B、轩竹生物-B等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1230","BK1572","02656","03696","02617","SG9999003461.SGD","00863","BK1170","02609","09606","02698","BK4588","02007","BK1117","BK1175","BK1231","NWSGY","BK1207","01384","BK1124","BKEAY","CTRYY","BK4585","03660","BK1601","BK1141","00659","BK1160","QFIN","00023","07618","03887","02788"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617066845?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势,三生制药 涨9.83%,基石药业-B涨6.84%,荣昌生物涨6.31%,映恩生物-B涨5.98%,四环医药涨5.76%,恒瑞医药涨5.77%,君圣泰医药-B涨5.58%,康诺亚-B涨5.31%,复宏汉霖涨5.02%。交银国际表示,本周各公司业绩预告陆续发布,该机构建议持续关注财务表现超预期、盈利路径清晰的公司,其业绩兑现有望催化板块行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","HK0000165453.HKD","159992","BK1574","02511","HK0000500386.USD","02696","09606","BK1593","02616","HK0000320264.USD","BK1583","01530","HK0000306701.USD","LU2543165471.USD","LU1969619763.USD","00460","BK1161","LU0359202008.SGD","LU1023057109.AUD","09995","BK1515","HK0000252160.HKD","02162","HK0000306685.HKD","BK1587","BK1191","HK0000252152.HKD","LU0359201612.USD","LU0359201885.HKD","BK1600","06978","HK0000320223.HKD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2617552012","title":"每日卖空追踪 | 映恩生物-B 03月05日卖空量成交3.97万股,卖空比例为4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617552012?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 16:30","pubTimestamp":1772699442,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月05日,涨2.18%,卖空量成交3.97万股,较上一交易日减少74.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163604a6a5db84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163604a6a5db84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","BK1161","09606","HK0000500386.USD","LU2543165471.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2617520171","title":"映恩生物-B盘中异动 早盘急速拉升5.05%报299.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617520171?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 10:11","pubTimestamp":1772676664,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘10时11分,映恩生物-B股票出现波动,股价急速拉升5.05%。截至发稿,该股报299.400港元/股,成交量12.2539万股,换手率0.14%,振幅2.67%。资金方面,该股资金流入1664.75万港元,流出1395.48万港元。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。映恩生物-B股票所在的生物技术行业中,整体涨幅为2.50%。映恩生物-B公司简介:映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305101104a6a46962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305101104a6a46962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","09606","BK1161","HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2616032538","title":"映恩生物-B03月03日主力净流出191.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616032538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616032538?lang=zh_cn&edition=fundamental","pubTime":"2026-03-03 16:15","pubTimestamp":1772525707,"startTime":"0","endTime":"0","summary":"03月03日, 映恩生物-B股价跌1.14%,报收295.60元,成交金额2.4亿元,换手率0.92%,振幅6.02%,量比1.11。映恩生物-B今日主力资金净流出191.1万元,上一交易日主力净流入1084.8万元。该股近5个交易日下跌12.78%,主力资金累计净流入2283.0万元;近20日主力资金累计净流入5066.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161518a69c948a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161518a69c948a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252152.HKD","09606","HK0000252160.HKD","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2616596093","title":"医药行业跟踪报告:中国创新ADC闪耀ASCO GU,长效三靶点减肥药二期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2616596093","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616596093?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 22:06","pubTimestamp":1772460407,"startTime":"0","endTime":"0","summary":"投资要点:医药板块行情复盘:本周为春节假期后第一周,市场温和反弹,沪深300指数+1.08%,但A股医药板块整体表现平淡,SW医药生物指数+0.50%,在申万一级行业指数中排名25/31。中国创新ADC闪耀ASCOGU,映恩DB-1311生存获益数据优异。联邦三靶点减肥药UBT251二期临床成功,将尽快启动三期临床研究。2月24日,联邦制药发布公告,其自主研发的长效GLP-1/GIP/GCG三靶点激动剂UBT251注射液已完成在中国超重/肥胖患者中的二期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","03933","02268","09606","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}